Highlight transcript below to create clipTranscript: Print | Email Go Click text to jump within videoMon 01 Apr 13 | 02:38 PM ET Johnson & Johnson just won approval for a new diabetes drug, and the stock is at an all-time high today. Anthony Butler, Barclays, offers insight.Tuesday, July 16, 2013
Johnson & Johnson Hits All-Time High
Highlight transcript below to create clipTranscript: Print | Email Go Click text to jump within videoMon 01 Apr 13 | 02:38 PM ET Johnson & Johnson just won approval for a new diabetes drug, and the stock is at an all-time high today. Anthony Butler, Barclays, offers insight.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment